SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-24-005572
Filing Date
2024-08-13
Accepted
2024-08-13 16:32:41
Documents
49
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT xenetic_i10q-063024.htm   iXBRL 10-Q 551062
2 CONFIDENTIAL SEPARATION AGREEMENT AND GENERAL RELEASE, DATED JUNE 19, 2024, BETW xenetic_ex1001.htm EX-10.1 76606
3 CONFIDENTIAL SEPARATION AGREEMENT AND GENERAL RELEASE, DATED JUNE 19, 2024, BETW xenetic_ex1002.htm EX-10.2 76480
4 AMENDMENT TO EMPLOYMENT AGREEMENT, DATED JUNE 18, 2024, BETWEEN JAMES F. PARSLOW xenetic_ex1003.htm EX-10.3 14803
5 CERTIFICATION xenetic_ex3101.htm EX-31.1 10105
6 CERTIFICATION xenetic_ex3102.htm EX-31.2 9951
7 CERTIFICATION xenetic_ex3201.htm EX-32.1 4307
  Complete submission text file 0001683168-24-005572.txt   2804679

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE xbio-20240630.xsd EX-101.SCH 17977
9 XBRL CALCULATION FILE xbio-20240630_cal.xml EX-101.CAL 24829
10 XBRL DEFINITION FILE xbio-20240630_def.xml EX-101.DEF 81530
11 XBRL LABEL FILE xbio-20240630_lab.xml EX-101.LAB 194191
12 XBRL PRESENTATION FILE xbio-20240630_pre.xml EX-101.PRE 163048
52 EXTRACTED XBRL INSTANCE DOCUMENT xenetic_i10q-063024_htm.xml XML 253616
Mailing Address 945 CONCORD ST. FRAMINGHAM MA 01701
Business Address 945 CONCORD ST. FRAMINGHAM MA 01701 781-778-7720
Xenetic Biosciences, Inc. (Filer) CIK: 0001534525 (see all company filings)

IRS No.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37937 | Film No.: 241202224
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)